The first new guidance in five years tackles risk stratification of patients, diagnostic tools, and new options in surgical and transcatheter treatments for patients with aortic stenosis and mitral regurgitation.
Heartwire
via Medscape news
Heartwire
via Medscape news
No comments:
Post a Comment